|
RGMB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.644780E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.680180E-01 |
| Normal-vs-Stage2 |
9.017300E-03 |
| Normal-vs-Stage3 |
2.999000E-01 |
| Normal-vs-Stage4 |
9.341800E-01 |
| Stage1-vs-Stage2 |
9.854300E-02 |
| Stage1-vs-Stage3 |
6.914000E-01 |
| Stage1-vs-Stage4 |
6.344200E-01 |
| Stage2-vs-Stage3 |
6.288600E-01 |
| Stage2-vs-Stage4 |
3.315800E-01 |
| Stage3-vs-Stage4 |
5.362200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.040600E-01 |
| Normal-vs-AfricanAmerican |
1.642960E-01 |
| Normal-vs-Asian |
3.336000E-01 |
| Caucasian-vs-AfricanAmerican |
7.423000E-01 |
| Caucasian-vs-Asian |
7.116200E-01 |
| AfricanAmerican-vs-Asian |
8.978200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.622590E-01 |
| Normal-vs-Female |
4.392400E-01 |
| Male-vs-Female |
7.547400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.609400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.120480E-02 |
| Normal-vs-Age(61-80Yrs) |
8.429600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.000400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.953800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.132000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.541800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.889850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.910200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.337180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.606800E-01 |
| Normal-vs-Grade 2 |
4.151000E-01 |
| Normal-vs-Grade 3 |
7.21279999948976E-07 |
| Normal-vs-Grade 4 |
8.988800E-01 |
| Grade 1-vs-Grade 2 |
6.133600E-01 |
| Grade 1-vs-Grade 3 |
8.922700E-03 |
| Grade 1-vs-Grade 4 |
9.723800E-01 |
| Grade 2-vs-Grade 3 |
2.30179999949343E-07 |
| Grade 2-vs-Grade 4 |
7.457800E-01 |
| Grade 3-vs-Grade 4 |
2.235200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.719900E-02 |
| Normal-vs-ccB subtype |
9.722200E-01 |
| ccA subtype-vs-ccB subtype |
4.605200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.742100E-03 |
| Normal-vs-N1 |
4.869000E-01 |
| N0-vs-N1 |
3.861800E-01 |
|
|
